OSR Health (OSRHW) Selling, General & Administrative (2022 - 2026)
OSR Health (OSRHW) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.12 Bn | 131.27 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.30 Bn | 77.31 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 62.84 Bn | 57.66 Bn | 1.37 Bn | 1.13 Bn |
| 4 | Moderna | 55.67 Bn | 50.53 Bn | 52.00 Mn | 216.00 Mn |
| 5 | BeOne Medicines | 41.43 Bn | 36.33 Bn | 1.53 Bn | 593.21 Mn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | 347.92 Mn |
| 7 | BioNTech SE | 27.47 Bn | 9.08 Bn | 668.28 Mn | -196.26 Mn |
| 8 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.03 Bn | 25.87 Bn | 358.27 Mn | 247.47 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | 3.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.83 Mn |
| Dec 31, 2025 | 6.52 Mn |
| Sep 30, 2025 | 4.07 Mn |
| Jun 30, 2025 | 5.26 Mn |
| Mar 31, 2025 | 3.09 Mn |
| Dec 31, 2024 | 1.77 Mn |
| Sep 30, 2024 | 3.75 Mn |
| Jun 30, 2024 | 3.44 Mn |
| Mar 31, 2024 | 3.54 Mn |
| Dec 31, 2023 | 861,894.00 |
| Sep 30, 2023 | 410,431.00 |
| Jun 30, 2023 | 280,273.00 |
| Mar 31, 2023 | 278,102.00 |
| Dec 31, 2022 | 14,252.00 |
| Sep 30, 2022 | 20,022.00 |
| Jun 30, 2022 | 988.00 |